Suppliers / Swiss Caps

Swiss Caps

Switzerland Updated 9 July 2026

Swiss Caps is a finished-dose manufacturer based in Switzerland. It appears in 287 regulatory filings across 12 regulators, without an active US DMF or CEP on file. Its filings concentrate with MCAZ (ZW), EDA (EG) and NPRA (MY). Its GMP standing is certified by ZLG (DE), EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 29 June 2023 as VAI.

0
active US DMFs
0
valid CEPs
5
registered plants 1 with an FDA FEI number
287
filings across 12 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 29 June 2023 VAI US FDA
  • 27 September 2019 NAI US FDA
  • 16 June 2017 VAI US FDA
  • 31 October 2014 NAI US FDA
  • 23 November 2012 VAI US FDA
  • 25 November 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Kirchberg, United Arab Emirates Not on file
Switzerland, Switzerland 3002808292
Kirchberg Sg, Switzerland Not on file
Bavaria, Germany Not on file
Bad Aibling, Germany Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
MCAZ (ZW) 184 None
EDA (EG) 64 None
NPRA (MY) 13 None
NMRC (NA) 5 None
DIGEMAPS (DO) 5 None
ARCSA (EC) 5 None
ZLG (DE) None 10
EMA None 3
US FDA None 1

Questions about Swiss Caps

Does Swiss Caps hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Swiss Caps. It does have 287 filings with 12 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Swiss Caps FDA-registered?
One site operated by Swiss Caps carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Swiss Caps's last inspection go?
The most recent inspection on record closed on 29 June 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 6 inspections are on file.
Where does Swiss Caps manufacture?
5 registered sites are on record, in United Arab Emirates, Switzerland and Germany (Kirchberg, Switzerland and Kirchberg Sg among others). Every site is listed on this page with the register it came from.
Which regulators recognise Swiss Caps's GMP?
Current GMP certificates are on record from ZLG (DE), EMA and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Swiss Caps comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 29 June 2023.

Comparable suppliers

Acino Pharma also in Switzerland Alpex Pharma also in Switzerland Baccinex also in Switzerland Bracco Suisse also in Switzerland Drossapharm also in Switzerland

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates